Recurrent Oropharyngeal Squamous Cell Carcinoma Terminated Phase 2 Trials for MK-1775 (DB11740)

IndicationStatusPhase
DBCOND0037158 (Recurrent Oropharyngeal Squamous Cell Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02196168Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerTreatment